InsiderTrades

Form 4 for WHWK Whitehawk Therapeutics, Inc.

Accepted 2025-03-03 00:00:00 ET · period of report 2025-03-01 · accession 0001415889-25-006316 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-03-03 2025-03-03 WHWK Lennon David James CEO, Dir S - Sale+OE $2.35 -5,690 33.4K -15% -$13.4K
D 2025-03-03 2025-03-01 WHWK Lennon David James CEO, Dir M - OptEx — +16.2K 39.1K +71% —
D 2025-03-03 2025-03-01 WHWK Lennon David James CEO, Dir M - OptEx $0.00 -16.2K 48.8K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-03-03 S D 5,690 $2.35 33,429 D — —
2 Common Common Stock 2025-03-01 M A 16,250 — 39,119 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.
3 Derivative Restricted Stock Units 2025-03-01 M D 16,250 $0.00 48,750 D — · — to — 16,250 Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock. (F3) Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.